Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Cap	25	72	143	26	256	385
Market Cap Growth	-67.08%	-49.20%	442.15%	-89.72%	-33.43%	1676.65%
Enterprise Value	-36.84	-7.04	25.1	11.91	190.58	284.96
Last Close Price	0.63	2.50	5.28	3.60	37.20	63.90
PE Ratio	-	-1.50	-3.47	-0.42	-5.04	-4.35
PS Ratio	29.78	149.16	134.11	-115.95	230.96	353.11
PB Ratio	0.46	1.03	1.25	2.18	3.96	4.18
P/TBV Ratio	0.44	1.10	0.89	2.07	3.79	2.00
P/FCF Ratio	-	-1.71	-5.51	-0.53	-5.63	-31.15
P/OCF Ratio	-	-1.72	-5.53	-0.53	-5.66	-31.86
EV/Sales Ratio	-	-14.49	23.59	-52.45	171.86	261.55
EV/EBITDA Ratio	-	0.13	-0.76	-0.20	-4.00	-15.99
EV/EBIT Ratio	-	0.13	-0.76	-0.20	-3.99	-15.89
EV/FCF Ratio	-	0.17	-0.97	-0.24	-4.19	-23.08
Debt / Equity Ratio	0.02	0.01	0.01	0.18	0.04	0.04
Debt / EBITDA Ratio	-0.03	-0.03	-0.06	-0.05	-0.06	-0.21
Debt / FCF Ratio	-0.02	-0.04	-0.08	-0.05	-0.07	-0.30
Net Debt / Equity Ratio	-1.18	-1.12	-1.02	-1.15	-1.01	-1.08
Net Debt / EBITDA Ratio	1.20	1.42	3.56	0.24	1.37	5.58
Net Debt / FCF Ratio	1.00	1.87	4.52	0.28	1.43	8.05
Asset Turnover	0.01	0.00	0.01	0.00	0.01	0.02
Quick Ratio	4.57	6.38	23.26	3.64	11.82	24.61
Current Ratio	4.67	6.51	23.55	3.83	12.32	24.85
Return on Equity (ROE)	-101.55%	-55.68%	-46.47%	-154.27%	-60.95%	-41.57%
Return on Assets (ROA)	-64.39%	-53.81%	-45.62%	-123.81%	-52.24%	-31.44%
Return on Invested Capital (ROIC)	1012.38%	2284.77%	-3499.36%	-3290.23%	-1840.24%	-748.52%
Return on Capital Employed (ROCE)	-75.50%	-58.84%	-48.90%	-138.81%	-55.25%	-33.49%
Earnings Yield	-285.32%	-66.80%	-28.79%	-236.39%	-19.84%	-23.00%
FCF Yield	-257.62%	-58.33%	-18.13%	-189.70%	-17.75%	-3.21%
Buyback Yield / Dilution	-125.67%	-4.43%	-90.68%	0.03%	-4.09%	-29.82%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q